Abstract
4754 Background: Cox-2 is over expressed in patients (pts) with HRPC and is an independent predictor of survival. C is a Cox-2 inhibitor. E is a derivative of doxorubicin with lower cardiotoxicity....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
